Spironolactone as a nonspecific treatment for primary aldosteronism.
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine; D001794:Blood Pressure; D001806:Blood Urea Nitrogen; D001835:Body Weight; D002245:Carbon Dioxide / Q000097:blood; D003404:Creatinine / Q000097:blood / Q000652:urine; D004039:Diet, Sodium-Restricted; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006929:Hyperaldosteronism / Q000188:drug therapy* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010953:Plasma Volume; D011188:Potassium / Q000097:blood / Q000652:urine; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood / Q000652:urine; D013148:Spironolactone / Q000627:therapeutic use*
D006852:Hydrochlorothiazide; D002245:Carbon Dioxide; D013148:Spironolactone; D000450:Aldosterone; D005665:Furosemide; D012964:Sodium; D003404:Creatinine; D012083:Renin; D011188:Potassium